INMUNE BIO, INC. Form of Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • May 16th, 2024 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 16th, 2024 Company IndustryThis NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the 14th day of May 2024, by and between ________ (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant by the Compensation Committee of the Board of Directors of the Company on May 14, 2024 (the “Grant Date”) pursuant to the INmune Bio Inc. 2021 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.
INMUNE BIO, INC. Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • March 24th, 2022 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 24th, 2022 Company IndustryThis NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the 21st day of March 2022, by and between (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant by the Compensation Committee of the Board of Directors of the Company on March 21, 2022 (the “Grant Date”) pursuant to the Company's 2021 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.
INMUNE BIO, INC. Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • June 24th, 2021 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJune 24th, 2021 Company IndustryThis NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the ___ day of 2021, by and between (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant by the Compensation Committee of the Board of Directors of the Company on June , 2021 (the “Grant Date”) pursuant to the Company’s 2021 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.
INMUNE BIO, INC. Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • August 30th, 2018 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 30th, 2018 Company IndustryThis NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the ___ day of _____, 20___, to be effective as of such sate (the “Grant Date”), by and between ___________ (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant pursuant to the Company's 2017 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.
INMUNE BIO, INC. Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • June 13th, 2018 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJune 13th, 2018 Company IndustryThis NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the ___ day of _____, 20___, to be effective as of such sate (the “Grant Date”), by and between ___________ (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant pursuant to the Company's 2017 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.